Experts on a NIH COVID-19 panel have ties to companies involved in coronavirus treatment

Eight members of NIH’s COVID-19 Treatment Guidelines Panel list financial ties to Gilead Sciences, whose COVID-19 drug remdesivir has been touted by Dr. Anthony Fauci.

Just The News: Members of the National Institutes of Health’s COVID-19 Treatment Guidelines Panel have financial ties to a company behind clinical trials of a drug to treat coronavirus, as well as to another large pharmaceutical company involved with developing a COVID-19 vaccine.

According to the NIH, members of the panel include U.S. physicians, statisticians, and other experts who are developing treatment guidelines on COVID-19 “intended for healthcare providers.”

A total of eight panel members list a financial relationship with Gilead Sciences on the panel’s Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics document: Judith Aberg, MD, Adaora Adimora, MD, Jason Baker, MD, Roger Bedimo, MD, Eric Daar, MD, David V. Glidden, PhD, Susanna Naggie, MD, and Pablo Tebas, MD.   KEEP READING

6 Comments on Experts on a NIH COVID-19 panel have ties to companies involved in coronavirus treatment

  1. In the end, it always turns out to be the money.

    Interestingly, the Bible says more about money than it does about prayer.

    2
  2. Disband the NIH, our change the name to National Health Stick Investors Group.
    Prosecute the greedy bastards.

    1
  3. Remember when Conflict Of Interest was a thing?!

    Yes, yes, and there was a thing termed Ethics, too!

    1

Comments are closed.